Scientific Publications

Search by Keyword(s)
Found 7 results

Filters: Author is Salvesen, HB  [Clear All Filters]

Search Results

  • Showing 1-7 of 7 Results
2014
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.Berg, A., Hoivik EA, Mjøs S., Holst F., Werner HM, Tangen IL, Taylor-Weiner A., Gibson WJ, Kusonmano K., Wik E., Trovik J., Halle MK, Oyan AM, Kalland KH, Cherniack AD, Beroukhim R., Stefansson I., Mills GB, Krakstad C., and Salvesen HB Oncotarget, 2014/11/04, (2014) Read More / View Supplemental Materials
Abstract
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.Wik, E., Trovik J., Kusonmano K., Birkeland E., Raeder MB, Pashtan I., Hoivik EA, Krakstad C., Werner HM, Holst F., Mjøs S., Halle MK, Mannelqvist M., Mauland KK, Oyan AM, Stefansson IM, Petersen K., Simon R., Cherniack AD, Meyerson M., et al. Gynecologic oncology, 2014/07/01, (2014) Read More / View Supplemental Materials
Abstract
2013
Landscape of genomic alterations in cervical carcinomas.Ojesina, AI, Lichtenstein L., Freeman SS, Pedamallu CS, Imaz-Rosshandler I., Pugh TJ, Cherniack AD, Ambrogio L., Cibulskis K., Bertelsen B., Romero-Cordoba S., Treviño V., Vazquez-Santillan K., Guadarrama AS, Wright AA, Rosenberg MW, Duke F., Kaplan B., Wang R., Nickerson E., et al. Nature, 2013/12/25, (2013) Read More / View Supplemental Materials
Abstract
Integrated genomic characterization of endometrial carcinoma.Cancer Genome Atlas Research, Network, Genome sequencing centres: Broad Institute, Getz G., Gabriel SB, Cibulskis K., Lander E., Sivachenko A., Sougnez C., Lawrence M., Washington University in St Louis, Kandoth C., Dooling D., Fulton R., Fulton L., Kalicki-Veizer J., McLellan MD, O'Laughlin M., Schmidt H., Wilson RK, Ye K., et al. Nature, 2013/05/02, Volume 497, Issue 7447, p.67-73, (2013) Read More / View Supplemental Materials
Abstract
2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.Salvesen, HB, Carter SL, Mannelqvist M., Dutt A., Getz G., Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J., Wik E., Greulich H., Bø TH, Jonassen I., Thomas RK, Zander T., Garraway LA, Oyan AM, Sellers WR, Kalland KH, et al. Proceedings of the National Academy of Sciences of the United States of America, 2009/03/24, Volume 106, Issue 12, p.4834-9, (2009) Read More / View Supplemental Materials
Abstract
2008
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.Hoshida, Y., Villanueva A., Kobayashi M., Peix J., Chiang DY, Camargo A., Gupta S., Moore J., Wrobel MJ, Lerner J., Reich M., Chan JA, Glickman JN, Ikeda K., Hashimoto M., Watanabe G., Daidone MG, Roayaie S., Schwartz M., Thung S., et al. The New England journal of medicine, 2008/11/06, Volume 359, Issue 19, p.1995-2004, (2008) Read More / View Supplemental Materials
Abstract
Drug-sensitive FGFR2 mutations in endometrial carcinoma.Dutt, A., Salvesen HB, Chen TH, Ramos AH, Onofrio RC, Hatton C., Nicoletti R., Winckler W., Grewal R., Hanna M., Wyhs N., Ziaugra L., Richter DJ, Trovik J., Engelsen IB, Stefansson IM, Fennell T., Cibulskis K., Zody MC, Akslen LA, et al. Proceedings of the National Academy of Sciences of the United States of America, 2008/06/24, Volume 105, Issue 25, p.8713-7, (2008) Read More / View Supplemental Materials
Abstract
  • Showing 1-7 of 7 Results